Literature DB >> 26228063

Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer.

Ion Cristóbal1, Rebeca Manso2, Paula González-Alonso2, Juan Madoz-Gurpide2, Federico Rojo2, Jesús García-Foncillas3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26228063     DOI： 10.1007/s00268-015-3176-4

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

1.  miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

Authors:  Valentina Boni; Nerea Bitarte; Ion Cristobal; Ruth Zarate; Javier Rodriguez; Evaristo Maiello; Jesus Garcia-Foncillas; Eva Bandres
Journal:  Mol Cancer Ther       Date:  2010-07-20       Impact factor: 6.261

2.  MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Cristina Caramés; Ion Cristóbal; Víctor Moreno; Laura del Puerto; Irene Moreno; María Rodriguez; Juan P Marín; Andrea V Correa; Roberto Hernández; Víctor Zenzola; Tatiana Hernández; Ana León; José I Martín; Paloma Sánchez-Fayos; Damián García-Olmo; Federico Rojo; Ajay Goel; María J Fernandez-Aceñero; Jesús García-Foncillas
Journal:  Int J Colorectal Dis       Date:  2015-05-08       Impact factor: 2.571

3.  Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis.

Authors:  Kohei Shigeta; Yoshiyuki Ishii; Hirotoshi Hasegawa; Koji Okabayashi; Yuko Kitagawa
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

4.  Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.

Authors:  R Soong; N Shah; M Salto-Tellez; B C Tai; R A Soo; H C Han; S S Ng; W L Tan; N Zeps; D Joseph; R B Diasio; B Iacopetta
Journal:  Ann Oncol       Date:  2008-02-01       Impact factor: 32.976

5.  Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.

Authors:  Jun Deng; Wan Lei; Jian-Chun Fu; Ling Zhang; Jun-He Li; Jian-Ping Xiong
Journal:  Biochem Biophys Res Commun       Date:  2013-11-23       Impact factor: 3.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.